Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/45162
Title: Cancer Prevention Europe
Authors: Wild, CP
Espina, C
Bauld, L
Bonanni, B
Brenner, H
Brown, K
Dillner, J
Forman, D
Kampman, E
Nilbert, M
Steindorf, K
Storm, H
Vineis, P
Baumann, M
Schüz, J
First Published: 22-Jan-2019
Publisher: Wiley, Federation of European Biochemical Societies
Citation: Molecular Oncology, 2019, 13 (3), pp. 528-534
Abstract: The case for cancer prevention in Europe is the same as for all other parts of the world. The number of cancers is increasing, driven by demographic change and evolution in the exposure to risk factors, while the cost of treating patients is likewise spiralling. Estimations suggest that around 40% of cancers in Europe could be prevented if current understanding of risk and protective factors was translated into effective primary prevention, with further reductions in cancer incidence and mortality by screening, other approaches to early detection, and potentially medical prevention. However, the infrastructure for cancer prevention tends to be fragmented between and within different countries in Europe. This lack of a coordinated approach recently led to the foundation of Cancer Prevention Europe (Forman et al., 2018), a collaborative network with the main aims of strengthening cancer prevention in Europe by increasing awareness of the needs, the associated required resources and reducing inequalities in access to cancer prevention across Europe. This article showcases the need for strengthening cancer prevention and introduces the objectives of Cancer Prevention Europe and its foreseen future role in reducing the European cancer burden.
DOI Link: 10.1002/1878-0261.12455
eISSN: 1878-0261
Links: https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.12455
http://hdl.handle.net/2381/45162
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © the authors, 2019. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
File Description SizeFormat 
Wild_et_al-2019-Molecular_Oncology.pdfPublished (publisher PDF)269.12 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.